Hyporesponsiveness in pediatric recipients

Pediatric Transplantation

Volumn 6, Issue 1, 2002, Pages 8-11

  Lapchak, Peter H ^a   Briscoe, David M ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; GRAFT VERSUS HOST REACTION; HISTOCOMPATIBILITY; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; TRANSPLANTATION;

CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT REJECTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; PROGNOSIS; RISK ASSESSMENT; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0036209443     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3046.2002.1e073.x     Document Type: Editorial

References (29)

1. High-dose peripheral blood stem cell infusion: A strategy to induce donor-specific hyporesponsiveness to allografts in pediatric renal transplant recipients
2. Quantitative studies on tissue transplantation immunity. III, Actively acquired tolerance
3. Effect of blood transfusions on subsequent kidney transplants
4. Blood transfusions and unresponsiveness to HL-A
5. Deliberate donorspecific blood transfusions prior to living related renal transplantation. A new approach
6. Are blood transfusions beneficial in the cyclosporine era?
7. Induction of high kidney graft survival rate by multiple transfusion
8. Improved allograft survival in nonidentical living related donor transplants usingdonorspecific blood transfusions
9. Donor-specific transfusions in living-related transplantation
10. Improved renal allograft survival following donor-specific transfusions. II. In vitro correlates of early (DST-type) rejection episodes
11. Risk factors for sensitization by blood transfusions. Comparison of the UW/Madison and UC/San Francisco donor-specific transfusion experience
12. A seven-year experience with donor-specific blood transfusions. Results and considerations for maximum efficacy
13. The lost chord: Microchimerism and allograft survival
14. Systemic chimerism in human female recipients of male livers
15. Chimerism and donorspecific nonreactivity 27-29 years after kidney allotransplantation
16. Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation
17. Donor dendritic cell persistence in organ allograft recipients in the absence of immunosuppression
18. Peripheral microchimerism in long-term cadaveric-kidney allograft recipients
19. Donor-specific transfusions have long-term beneficial effects for human renal allografts
20. The role of the allograft in the induction of donorspecific T cell hyporesponsiveness
21. The role of T-cell anergy in the maintenance of donor-specific hyporesponsiveness in renal transplant recipients
22. Why do we reject a graft? Role of indirect allorecognition in graft rejection
23. The role of T-cell costimulatory activation pathways in transplant rejection
24. Homeostatic T cell proliferation: How far can T cells be activated to self-ligands?
25. Identification and functional characterization of human CD4 (+) CD25 (+) T cells with regulatory properties isolated from peripheral blood
26. Human CD25 (+) CD4 (+) T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function
27. Pretransplant exposure to donor HLA-DR antigen in random transfusion units and the development of donor antigen-specific hyporeactivity
28. Pediatric kidney transplantation utilizing living unrelated donors: Anecdote or solution to the kidney shortage?
29. In renal transplantation, one size may not fit all